LU82411A1 - Epimere d du sel de diammonium d'un antibiotique d'oxa-b-lac-tame - Google Patents

Epimere d du sel de diammonium d'un antibiotique d'oxa-b-lac-tame Download PDF

Info

Publication number
LU82411A1
LU82411A1 LU82411A LU82411A LU82411A1 LU 82411 A1 LU82411 A1 LU 82411A1 LU 82411 A LU82411 A LU 82411A LU 82411 A LU82411 A LU 82411A LU 82411 A1 LU82411 A1 LU 82411A1
Authority
LU
Luxembourg
Prior art keywords
epimer
solution
diammonium salt
salt
oxa
Prior art date
Application number
LU82411A
Other languages
English (en)
French (fr)
Inventor
K Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LU82411A1 publication Critical patent/LU82411A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D505/00Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU82411A 1979-05-01 1980-04-29 Epimere d du sel de diammonium d'un antibiotique d'oxa-b-lac-tame LU82411A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/035,037 US4252953A (en) 1979-05-01 1979-05-01 Antibiotic crystalline epimer
US3503779 1979-05-01

Publications (1)

Publication Number Publication Date
LU82411A1 true LU82411A1 (fr) 1980-07-31

Family

ID=21880235

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82411A LU82411A1 (fr) 1979-05-01 1980-04-29 Epimere d du sel de diammonium d'un antibiotique d'oxa-b-lac-tame

Country Status (34)

Country Link
US (1) US4252953A (es)
EP (1) EP0018811B1 (es)
JP (1) JPS55153788A (es)
KR (1) KR840000078B1 (es)
AR (1) AR230450A1 (es)
AT (1) AT370108B (es)
AU (1) AU538283B2 (es)
BE (1) BE882980A (es)
BG (1) BG34905A3 (es)
CA (1) CA1138867A (es)
CH (1) CH646434A5 (es)
CS (1) CS226013B2 (es)
DD (1) DD150352A5 (es)
DE (1) DE3061751D1 (es)
DK (1) DK177980A (es)
EG (1) EG14719A (es)
ES (1) ES491085A0 (es)
FI (1) FI801345A (es)
FR (1) FR2455605A1 (es)
GB (1) GB2047707B (es)
GR (1) GR68202B (es)
HU (1) HU184750B (es)
IE (1) IE49775B1 (es)
IL (1) IL59912A (es)
IT (1) IT1141935B (es)
LU (1) LU82411A1 (es)
MY (1) MY8500601A (es)
NZ (1) NZ193528A (es)
PH (1) PH15596A (es)
PL (1) PL125579B1 (es)
PT (1) PT71140A (es)
RO (1) RO79684A (es)
SU (1) SU860705A3 (es)
ZA (1) ZA802475B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
WO2005035286A1 (de) * 2003-10-08 2005-04-21 Behr Gmbh & Co. Kg Bauteil, insbesondere hybridträger für ein fahrzeug, und verfahren zur herstellung eines derartigen bauteils sowie verwendung eines derartigen bauteils
ATE472461T1 (de) * 2003-10-08 2010-07-15 Behr Gmbh & Co Kg Verfahren und vorrichtung zur herstellung eines bauteils, insbesondere eines hybridbaudteils für einen quertr ger eines fahrzeugs sowie bauteil und verwendung eines bauteils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1158A (en) * 1976-03-25 1983-01-28 Shionogi & Co Arylmalonamido-1-oxadethiacephalosporins
CA1085392A (en) * 1976-03-25 1980-09-09 Masayuki Narisada Arylmalonamido-1-oxadethiacephalosporins
US4148997A (en) * 1977-11-07 1979-04-10 Yeda Research And Development Co., Ltd. 7-[Sulfomethyl)phenyl]acetamidocephalosporin derivatives
US4124762A (en) * 1977-11-07 1978-11-07 Yeda Research And Development Co., Ltd. 7-[(Pyridylthiomethyl)phenyl]acetamido-cephalosporin derivatives
US4125715A (en) * 1977-11-25 1978-11-14 Yeda Research And Development Co. Ltd. 7-[(Substituted-isothioureamethyl)phenyl]-acetamidocephalosporin derivatives

Also Published As

Publication number Publication date
PL125579B1 (en) 1983-05-31
IE800882L (en) 1980-11-01
AU538283B2 (en) 1984-08-09
BG34905A3 (en) 1983-12-15
PL223753A1 (es) 1981-02-13
CS226013B2 (en) 1984-03-19
IT8021697A0 (it) 1980-04-29
RO79684A (ro) 1982-08-17
JPH0118077B2 (es) 1989-04-03
DE3061751D1 (en) 1983-03-03
BE882980A (fr) 1980-10-27
GR68202B (es) 1981-11-10
PH15596A (en) 1983-02-28
ZA802475B (en) 1981-12-30
KR840000078B1 (ko) 1984-02-08
DK177980A (da) 1980-11-02
AR230450A1 (es) 1984-04-30
SU860705A3 (ru) 1981-08-30
FR2455605B1 (es) 1983-05-27
GB2047707A (en) 1980-12-03
EP0018811A1 (en) 1980-11-12
GB2047707B (en) 1983-05-18
JPS55153788A (en) 1980-11-29
KR830002779A (ko) 1983-05-30
AU5791480A (en) 1980-11-06
MY8500601A (en) 1985-12-31
FR2455605A1 (fr) 1980-11-28
US4252953A (en) 1981-02-24
ATA220980A (de) 1982-07-15
ES8105316A1 (es) 1981-05-16
IE49775B1 (en) 1985-12-11
IT1141935B (it) 1986-10-08
DD150352A5 (de) 1981-08-26
HU184750B (en) 1984-10-29
EG14719A (en) 1985-06-30
PT71140A (en) 1980-05-01
ES491085A0 (es) 1981-05-16
CA1138867A (en) 1983-01-04
EP0018811B1 (en) 1983-01-26
IL59912A (en) 1984-02-29
AT370108B (de) 1983-03-10
FI801345A (fi) 1980-11-02
CH646434A5 (fr) 1984-11-30
NZ193528A (en) 1982-03-23

Similar Documents

Publication Publication Date Title
HU211862A9 (en) Azithromycin dihydrate
CS220790B2 (en) Method of separation of the -6-methoxy-alpha-methyl-2-naphtalene vinegar acid from the mixtures of the a/-/-6-methoxy-alpha-methyl-2/naphtalene vinegar acid or salts thereof
US20050080255A1 (en) Crystalline cefdinir potassium dihydrate
LU82411A1 (fr) Epimere d du sel de diammonium d'un antibiotique d'oxa-b-lac-tame
CN108586491B (zh) 一种盐酸头孢他美酯的制备方法
KR930007809B1 (ko) 항생물질유도체의 정제방법
US5210288A (en) Process for the preparation of d-(-)-4-hydroxyphenylglycine and l-(+)-4-hydroxyphenylglycine, starting from d.l.-4-hydroxyphenylglycine
JPH03240793A (ja) アンフォテリシンbの精製方法および組成物
US4594417A (en) Crystalline antibiotic salt
LU82384A1 (fr) Cristallisation du sel sesqui-sodique d'un diacide d'oxa-b-lactame antibiotique
US4400503A (en) Purification of syn-7-[[(2-amino-4-thiazolyl)(methoxyimino) acetyl]amino]-3-methyl-3-cephem-4-carboxylic acid
US3947414A (en) Cefamandole derivatives
US4048158A (en) d-α-Isobutylsulfobenzylpenicillin hemi-solvate crystals
US3947415A (en) Cefamandole derivatives
KR830002350B1 (ko) 1-설포닐-2-아미노벤즈 이미다졸류의 신 및 안티옥심의 분리방법
JPS593476B2 (ja) 光学活性クロルフエニラミン・アシルフエニルグリシン塩及びその製造法
BE843055R (fr) Procede de preparation d'un complexe peu soluble de cephalexine
WO2023181053A1 (en) An improved process for purification of robenacoxib
CA2651010A1 (fr) Procede de preparation de particules de stiripentol ayant une granulometrie definie
CN118324648A (zh) (r)-特布他林苯磺酸盐a晶型和b晶型及其制备方法
CH637967A5 (fr) Produit d'addition du n,n-dimethylacetamide et d'un derive d'un acide cephem-4-carboxylique et procede de sa preparation.
CS197138B1 (cs) Způsob přípravy acetoxymethylestertt benzylpenicilinu
EP0197757A2 (en) Crystalline anhydrous sodium 19-deoxyaglycone dianemycin
HU180161B (en) Process for preparing crystalline,stable prostaglandin f down 2alpha with a melting point over 35 c from contaminated prostaglandin f down 2alpha containing 50-98% prostaglandin f down 2alpha
HU180056B (hu) Üj eljárás ergotoxin-típusú alkaloidok előállítására anyarozsalkaloid keverékekből epimerizáció és/vagy sóképzés útjánn